Atea Pharmaceuticals (AVIR) Share-based Compensation (2019 - 2026)
Atea Pharmaceuticals' Share-based Compensation was $3.38 million in Q2 2026, down 27.6% from $4.67 million a year earlier and down 9.3% from the prior quarter.
Atea Pharmaceuticals (AVIR) Share-based Compensation (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Atea Pharmaceuticals' Share-based Compensation was $16.21 million through Jun 30, 2026, down 57.4% year-over-year; for FY2025, it was $20.72 million, down 60.0% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 22.7% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $51.77 million in FY2024 (+4.7%), $49.43 million in FY2023 (+5.8%), $46.72 million in FY2022 (+17.9%) and $39.62 million in FY2021 (+431.3%).
- The Q2 2026 figure marks the lowest quarterly Share-based Compensation since Q4 2020.
- Compared with a year earlier, Share-based Compensation has declined for six straight quarters, with an average decline of 37.1% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q4 2021 (growth of 302.4%); the worst was Q4 2025 (a decline of 67.9%).
- Per Business Quant data, AVIR's Share-based Compensation in the three quarters before Q2 2026 was $3.73 million (Q1 2026), $4.59 million (Q4 2025) and $4.52 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Atea Pharmaceuticals | 325.17 Mn | -781.44 Mn | - | 3.38 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | 4.52 Mn |
| Jun 30, 2025 | 4.67 Mn |
| Mar 31, 2025 | 6.95 Mn |
| Dec 31, 2024 | 14.30 Mn |
| Sep 30, 2024 | 12.16 Mn |
| Jun 30, 2024 | 12.72 Mn |
| Mar 31, 2024 | 12.59 Mn |
| Dec 31, 2023 | 12.16 Mn |
| Sep 30, 2023 | 12.38 Mn |
| Jun 30, 2023 | 12.35 Mn |
| Mar 31, 2023 | 12.54 Mn |
| Dec 31, 2022 | 11.65 Mn |
| Sep 30, 2022 | 11.50 Mn |
| Jun 30, 2022 | 11.91 Mn |
| Mar 31, 2022 | 11.66 Mn |
| Dec 31, 2021 | 11.35 Mn |
| Sep 30, 2021 | 10.99 Mn |
Atea Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AVIR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();